Abbott Laboratories Aktie
WKN: 850103 / ISIN: US0028241000
02.11.2023 14:48:45
|
Abbott Obtains FDA Approval For HPV Test To Run On Alinity M
(RTTNews) - Abbott (ABT) said it has received U.S. Food and Drug Administration approval for its molecular human papillomavirus or HPV screening solution, adding a powerful cancer screening tool for detecting high-risk HPV infections to the Alinity m family of diagnostic assays.
The Alinity m high risk (HR) HPV assay is approved as a test for HPV detection and for use in routine cervical cancer screening as per professional medical guidelines. The assay is also approved for use in combination with a Pap test, for patients and physicians who prefer to use both tests, called co-testing.
The Alinity m HR HPV assay delivers information on five risk groups covering the 14 different potentially cancer-causing genotypes of the virus, helping physicians identify not just if a patient has an HPV infection but whether that infection is caused by one (or more) of the types that may cause cancer.
For More Such Health News, visit rttnews.com

Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Abbott Laboratoriesmehr Nachrichten
18.07.25 |
Minuszeichen in New York: So entwickelt sich der S&P 500 am Freitagnachmittag (finanzen.at) | |
18.07.25 |
NASDAQ-Handel: NASDAQ Composite legt zum Start des Freitagshandels zu (finanzen.at) | |
17.07.25 |
Börse New York: NASDAQ Composite beendet den Handel im Plus (finanzen.at) | |
17.07.25 |
Zuversicht in New York: S&P 500 zeigt sich letztendlich fester (finanzen.at) | |
17.07.25 |
Gewinne in New York: NASDAQ Composite legt zu (finanzen.at) | |
17.07.25 |
S&P 500 aktuell: Am Nachmittag Pluszeichen im S&P 500 (finanzen.at) | |
17.07.25 |
Aufschläge in New York: S&P 500 am Donnerstagmittag fester (finanzen.at) | |
17.07.25 |
Gute Stimmung in New York: NASDAQ Composite verbucht mittags Zuschläge (finanzen.at) |
Analysen zu Abbott Laboratoriesmehr Analysen
Aktien in diesem Artikel
Abbott Laboratories | 107,00 | 0,32% |
|